Lincoln National Corp reports results for the quarter ended June 30 - Earnings Summary
Lincoln National Corp reports results for the quarter ended June 30 - Earnings Summary
Lincoln National Corp LNC.N reported quarterly adjusted earnings of $2.24 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $2.36. The mean expectation of fourteen analysts for the quarter was for earnings of $1.96 per share. Wall Street expected results to range from $1.65 to $2.10 per share.
Revenue rose 12.3% to $4.54 billion from a year ago; analysts expected $4.91 billion.
Lincoln National Corp's reported EPS for the quarter was $6.72.
The company reported quarterly net income of $1.32 billion.
Lincoln National Corp shares had risen by 17.2% this quarter and lost 7.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 6.2% in the last three months.
In the last 30 days, nine analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy," 7 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the life & health insurance peer group is "buy."
Wall Street's median 12-month price target for Lincoln National Corp is $45.00, about 7.9% above its last closing price of $41.43
This summary was machine generated from LSEG data July 30 at 11:01 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.96 | 2.24 | Beat |
Mar. 31 2026 | 1.58 | 1.66 | Beat |
Dec. 31 2025 | 1.90 | 2.21 | Beat |
Sep. 30 2025 | 1.86 | 2.04 | Beat |
Recent news on Lincoln National
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Nebius, CrowdStrike, Veeva Systems
Evercore sees limited fallout for life insurers from TWG global regulatory scrutiny